Clinically Tested Plant Extracts Calocurb (New Zealand) developed a hops extract (Amarasate) after 14 years of research
In emerging research on GLP-1 therapies and skin disease, inflammation is a recurring theme
The compound's stability in properly formulated products, combined with its gentle nature and low irritation potential, makes it ideal for both leave-on and rinse-off applications
Its especially helpful for individuals with low B12 levels due to stress, aging, or dietary limitations
At clinical doses under supervision, the most common side effects are mild nausea in the first week (typically resolves by day 7 to 10), injection site reactions (redness, minor swelling, localized soreness lasting 24 hours), and occasional transient fatigue or mild headache in the first few days